PORTLAND, Ore. , May 23, 2024 /PRNewswire/ -- Allied Market Research has recently published a report, titled, 'Degenerative Disc Disease Treatment Market Size, Share, Competitive Landscape and Trend Analysis Report by Drugs, By Treatment Type, By End Use, By Route of Administration : Global Opportunity Analysis and Industry Forecast, 2023-2032.' According to the report, the global degenerative disc disease treatment market generated $28 billion in 2022, and is anticipated to generate $46.2 billion by 2032, rising at a CAGR of 5.5% from 2023 to 2032..

俄勒冈州波特兰，2024年5月23日/PRNewswire/--Allied Market Research最近发布了一份报告，题为“退行性椎间盘疾病治疗市场规模、份额、竞争格局和趋势分析报告，按药物、治疗类型、最终用途、给药途径：2023-2032年全球机会分析和行业预测”。根据该报告，全球退行性椎间盘疾病治疗市场在2022年产生了280亿美元，预计到2032年将产生462亿美元，2023年至2032年的复合年增长率为5.5%。。

Request Sample of the Report on Degenerative Disc Disease Market Forecast 2032- https://www.alliedmarketresearch.com/request-sample/A269439

要求提供2032年退行性椎间盘疾病市场预测报告样本-https://www.alliedmarketresearch.com/request-sample/A269439

Prime Determinants of Growth

增长的主要决定因素

The increasing prevalence of degenerative disc disease (DDD) among the aging population, growing awareness about spine health and available treatment options, and the innovations in imaging technology & surgical tools are the factors expected to drive the growth of the global degenerative disc disease treatment market in the forecast period from 2023 to 2032.

在2023年至2032年的预测期内，预计将推动全球退行性椎间盘疾病治疗市场的增长，这些因素包括老年人群中退行性椎间盘疾病（DDD）的患病率不断上升，人们对脊柱健康和可用治疗选择的认识不断提高，以及成像技术和手术工具的创新。

However, the increasing availability of various alternative treatment and pain management methods for degenerative disc disease may restrict market growth in the coming future. Contrarily, technological innovations in medical technology, such as robotics, 3D printing, and advanced imaging techniques is expected to offer remunerative opportunities for the degenerative disc disease treatment market expansion during the forecast period..

然而，退行性椎间盘疾病的各种替代治疗和疼痛管理方法的日益增加可能会限制未来的市场增长。相反，在预测期内，机器人技术、3D打印和先进成像技术等医疗技术的技术创新有望为退行性椎间盘疾病治疗市场的扩张提供有报酬的机会。。

Report Coverage & Details:

报告覆盖范围和详细信息：

Report Coverage

报告覆盖率

Details

详细信息

Forecast Period

预测期

2023–2032

2023–2032

Base Year

基准年

2022

2022

Market Size in 2022

2022年市场规模

$28 billion

280亿美元

Market Size in 2032

2032年市场规模

$46.2 billion

462亿美元

CAGR

CAGR

5.5 %

5.5 %

No. of Pages in Report

报告页数

320

320

Segments covered

涵盖的细分市场

Drugs, Treatment Type, Route of Administration, End Use, and Region

药物，治疗类型，给药途径，最终用途和地区

Drivers

驱动程序

Increasing awareness about spine health and available treatment options Rising demand for minimally invasive procedures Growing prevalence of degenerative disc disease

人们对脊柱健康和可用治疗方案的认识不断提高，对微创手术的需求不断增加，退行性椎间盘疾病的患病率不断上升

Opportunities

机会

Advancements in medical technology Ongoing research & development

医疗技术的进步正在进行的研究与开发

Restraints

约束

Availability of various alternative treatment and pain management methods

各种替代治疗和疼痛管理方法的可用性

Have a Question? Connect to our Analyst- https://www.alliedmarketresearch.com/connect-to-analyst/A269439

有问题吗？连接我们的分析师-https://www.alliedmarketresearch.com/connect-to-analyst/A269439

Drugs: NSAIDs (Non-Steroidal Anti-Inflammatory Drugs) Sub-segment to be the Most Dominant by 2032

药物：到2032年，非甾体抗炎药（NSAIDs）亚类将成为最主要的药物

The NSAIDs (non-steroid anti-inflammatory drugs) sub-segment accounted for the largest global degenerative disc disease treatment market share of 35.1% in 2022 and is expected to hold major share and rise at a CAGR of 6.2% during the forecast period. NSAIDs' effectiveness in reducing pain, inflammation, and fever, their over-the-counter availability, and their ability to address multiple symptoms simultaneously drive their widespread use for various conditions like arthritis and minor ailments, which is driving the sub-segment's growth.

非甾体抗炎药（NSAIDs）子市场在2022年占全球退行性椎间盘疾病治疗市场份额最大，为35.1%，预计在预测期内将占据主要份额并以6.2%的复合年增长率增长。非甾体抗炎药在减轻疼痛，炎症和发烧方面的有效性，其非处方药的可用性以及同时解决多种症状的能力，推动了其广泛用于各种疾病，如关节炎和小病，这正在推动该细分市场的增长。

In addition, NSAIDs are a popular choice for self-medication..

此外，非甾体抗炎药是自我治疗的流行选择。。

Treatment Type: Physical Therapy Sub-segment to Flourish Immensely During the Forecast Period

治疗类型：在预测期内，物理治疗细分市场将蓬勃发展

The physical therapy sub-segment held the largest market share of 30.6% in 2022 and is predicted to grow at the highest CAGR of 6.5% during the forecast period. This dominant growth can be attributed to physical therapy's non-invasive nature, its proven effectiveness in reducing pain and improving mobility, and its use of therapeutic exercises and modalities like ultrasound and electrical stimulation make it a preferred treatment for degenerative disc disease.

2022年，理疗细分市场占据了30.6%的最大市场份额，预计在预测期内将以6.5%的最高复合年增长率增长。这种主要的增长可以归因于物理疗法的非侵入性，其在减轻疼痛和改善活动能力方面的有效性，以及其使用治疗性运动和超声波和电刺激等方式使其成为退行性椎间盘疾病的首选治疗方法。

This approach appeals to both patients and healthcare providers seeking conservative management options..

这种方法对寻求保守管理选择的患者和医疗保健提供者都有吸引力。。

Route of Administration: Oral Sub-segment to Witness Dominant Growth by 2032

给药途径：到2032年，口服细分市场将出现显性增长

The oral control sub-segment accounted for the largest global degenerative disc disease treatment market share of 65.5% in 2022 and is expected to be most dominant by growing at the highest CAGR of 6.0% during the forecast period. This is mainly because oral medications for degenerative disc disease, such as NSAIDs, muscle relaxants, and analgesics, offer convenience and ease of administration, making them preferred by patients and healthcare providers.

2022年，口腔控制子市场占全球退行性椎间盘疾病治疗市场份额的65.5%，预计在预测期内以6.0%的最高复合年增长率增长，将成为最具优势的市场。这主要是因为用于退行性椎间盘疾病的口服药物，如非甾体抗炎药，肌肉松弛剂和镇痛药，提供了方便和易于给药，使其成为患者和医疗保健提供者的首选。

Their availability over-the-counter or with a prescription ensures accessibility in hospitals, clinics, and pharmacies, providing flexibility in managing the condition..

他们的非处方药或处方药的可用性确保了医院，诊所和药房的可及性，为管理病情提供了灵活性。。

End Use: Hospitals Sub-segment to Thrive Significantly During the Forecast Period

最终用途：医院细分市场在预测期内将显著繁荣

The hospitals sub-segment held the largest market share of 45.5% in 2022 and is predicted to grow at the highest CAGR of 6.2% during the forecast period. This is mainly because specialized departments in hospitals dedicated to orthopedics, neurology, or spine care, equipped with advanced diagnostic tools and treatment modalities enable comprehensive care for patients with complex spinal conditions.

2022年，医院细分市场占据了45.5%的最大市场份额，预计在预测期间将以6.2%的最高复合年增长率增长。这主要是因为专门从事骨科，神经病学或脊柱护理的医院的专业部门配备了先进的诊断工具和治疗方式，可以为患有复杂脊柱疾病的患者提供全面的护理。

This infrastructure drives hospitals to become preferred destinations for specialized treatment of degenerative disc disease..

这一基础设施促使医院成为退行性椎间盘疾病专业治疗的首选目的地。。

For Purchase Enquiry- https://www.alliedmarketresearch.com/purchase-enquiry/A269439

对于采购询价-https://www.alliedmarketresearch.com/purchase-enquiry/A269439

Region: North America Market to Hold Major Share by 2032

地区：到2032年，北美市场将占据主要份额

The North America degenerative disc disease treatment market accounted for the largest share of 34.1% in 2022 and is predicted to continue to hold major share by 2032. This is mainly due to the advancements in medical technology, rising healthcare expenditure, and increased patient awareness. Besides, the increasing prevalence of degenerative disc disease (DDD) attributed to aging populations and sedentary lifestyles is another factor driving the regional market growth..

2022年，北美退行性椎间盘疾病治疗市场占34.1%的最大份额，预计到2032年将继续占据主要份额。这主要是由于医疗技术的进步，医疗保健支出的增加以及患者意识的提高。此外，人口老龄化和久坐不动的生活方式导致的退行性椎间盘疾病（DDD）患病率的增加是推动区域市场增长的另一个因素。。

Leading Players in the Degenerative Disc Disease Treatment Market:

退行性椎间盘疾病治疗市场的主要参与者：

Eli Lilly and Company

礼来公司

Spine BioPharma

Spine BioPharma

Novartis AG

诺华

FibroGenesis

纤维发生

Ferring B.V.

Ferring B.V。

Pfizer Inc.

辉瑞公司。

AstraZeneca Plc

阿斯特捷利康公司

Medtronic plc

美敦力公司

DiscGenics, Inc.

DiscGenics公司。

Braun Melsungen AG

Braun Melsungen AG

The report provides a detailed analysis of the key players of the global degenerative disc disease treatment market. These players are employing various strategies including launching new products, entering collaborations, expanding operations, forming joint ventures, and signing agreements, all aimed at boosting their market share and securing their competitive position across different regions.

该报告详细分析了全球退行性椎间盘疾病治疗市场的主要参与者。这些参与者正在采用各种策略，包括推出新产品、开展合作、扩大业务、组建合资企业和签署协议，所有这些策略都旨在提高其市场份额并确保其在不同地区的竞争地位。

The report is valuable in highlighting business performance, operating segments, product portfolio, and strategic moves of market players to showcase the competitive scenario..

该报告有助于突出业务表现、运营部门、产品组合以及市场参与者的战略举措，以展示竞争情景。。

AVENUE- A Subscription-Based Library (Premium on-demand, subscription-based pricing model) Offered by Allied Market Research:

AVENUE-Allied Market Research提供的基于订阅的图书馆（按需付费、基于订阅的定价模式）：

AMR introduces its online premium subscription-based library Avenue, designed specifically to offer cost-effective, one-stop solution for enterprises, investors, and universities. With Avenue, subscribers can avail an entire repository of reports on more than 2,000 niche industries and more than 12,000 company profiles.

AMR推出了基于在线付费订阅的图书馆大道，专门为企业、投资者和大学提供经济高效的一站式解决方案。有了Avenue，订阅者可以使用2000多个利基行业和12000多个公司简介的完整报告库。

Moreover, users can get an online access to quantitative and qualitative data in PDF and Excel formats along with analyst support, customization, and updated versions of reports..

此外，用户可以在线访问PDF和Excel格式的定量和定性数据，以及分析师支持、定制和更新版本的报告。。

Get an access to the library of reports at any time from any device and anywhere. For more details, follow the link: https://www.alliedmarketresearch.com/library-access

随时随地从任何设备访问报告库。有关更多详细信息，请访问以下链接：https://www.alliedmarketresearch.com/library-access

About Allied Market Research:

关于Allied Market Research：

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Wilmington, Delaware. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of 'Market Research Reports' and 'Business Intelligence Solutions.' AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domains.

Allied Market Research（AMR）是位于特拉华州威尔明顿的Allied Analytics LLP的全方位市场研究和商业咨询部门。Allied Market Research为全球企业以及中小型企业提供无与伦比的“市场研究报告”和“商业智能解决方案”AMR有针对性地提供商业见解和咨询，以帮助其客户做出战略性商业决策，并在各自的市场领域实现可持续增长。

AMR offers its services across 11 industry verticals including Life Sciences, Consumer Goods, Materials & Chemicals, Construction & Manufacturing, Food & Beverages, Energy & Power, Semiconductor & Electronics, Automotive & Transportation, ICT & Media, Aerospace & Defense, and BFSI..

AMR在11个垂直行业提供服务，包括生命科学、消费品、材料与化学品、建筑与制造、食品与饮料、能源与电力、半导体与电子、汽车与运输、ICT与媒体、航空航天与国防以及BFSI。。

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success.

我们与多家公司建立了专业的企业关系，这有助于我们挖掘市场数据，帮助我们生成准确的研究数据表，并确认市场预测的最大准确性。Allied Market Research首席执行官帕万·库马尔（PawanKumar）在激励和鼓励与公司相关的每个人保持高质量的数据方面发挥了重要作用，并以各种可能的方式帮助客户取得成功。

Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry..

我们发布的报告中提供的每一个数据都是通过与相关领域领先公司的高级官员进行初步访谈而提取的。我们的二级数据采购方法包括与业内知识渊博的专业人士和分析师进行深入的线上和线下研究和讨论。。